Timothy Coughlin Adc Therapeutics Sa (ADCT) insider trading activity

Timothy Coughlin is Director of ADC Therapeutics SA. Currently has a direct ownership of 40,000 shares of ADCT, which is worth approximately $114,000. The most recent transaction as insider was on Jun 03, 2025, when has been sold 40,000 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K

n/a 3M change

n/a 12M change

Total Value Held $114,000

TIMOTHY COUGHLIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 03 2025	BUY Grant, award, or other acquisition	-	40,000 Added 50.0%	40,000 Common Shares

Also insider at

LIFE

aTYR PHARMA INC Healthcare

TVTX

Travere Therapeutics, Inc. Healthcare

FATE

FATE THERAPEUTICS INC Healthcare